Riskpilot← Back to searchSign inGet full accessMedomina AB
ABActiveOrg 5590386156Ljusslingan 32Other education n.e.c. · NACE 8559Est. 20151 employees
Revenue 2025
SEK 994K
-34% vs 2024
EBITDA margin
73.4%
-13% vs 2024
Equity ratio
92.3%
Financial strength
Net profit 2025
SEK 622K
+5% vs 2024
| Revenue | SEK 994K | -34% |
| EBITDA | SEK 730K | -13% |
| Net profit | SEK 622K | +5% |
| Total assets | SEK 4,8M | +2% |
| Equity | SEK 4,5M | +5% |
| Employees | 1 | — |
Legal name
Medomina AB
Org number
5590386156
Legal form
Aktiebolag
NACE code
8559 · Other education n.e.c.
Founded
3 december 2015
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Föremålet för bolagets verksamhet är att bedriva medicinsk konsultation, utbildning inom ledarskap och organisation, administrativa tjänster, handel med värdepapper och fastigheter samt därmed förenlig verksamhet.
Address
Ljusslingan 32
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 483 | 1 324 | 1 466 | 1 507 | 994 |
| Staff expenses | — | −92 | −731 | −564 | −218 |
| EBITDA | 1 352 | 2 233 | 640 | 838 | 730 |
| Depreciation & amort. | −0 | — | −54 | −70 | 54 |
| EBIT | 1 352 | 2 233 | 586 | 768 | 784 |
| Net financials | −31 | −39 | −19 | −14 | 1 |
| Profit before tax | 1 322 | 2 194 | 567 | 753 | 785 |
| Tax | −273 | −454 | −118 | −161 | −163 |
| Net profit | 1 049 | 1 740 | 449 | 593 | 622 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 4 479 | 5 878 | 5 382 | 4 733 | 4 844 |
| Equity | 2 469 | 4 209 | 4 658 | 4 251 | 4 472 |
| Long-term debt | 1 283 | 783 | 0 | 0 | — |
| Short-term debt | 727 | 886 | 724 | 482 | 371 |
| Total debt | 2 010 | 1 669 | 724 | 482 | 371 |
EBITDA margin
73.4%
This company
15.8%
Market median
+365% vs market
20212025
Equity ratio
92.3%
This company
38.2%
Market median
+142% vs market
20212025
Return on equity
13.9%
This company
18.4%
Market median
+24% vs market
20212025
Net profit margin
62.6%
This company
8.1%
Market median
+673% vs market
20212025
Asset turnover
0.21×
This company
1.12×
Market median
-81% vs market
20212025
Debt / equity
0.08×
This company
0.62×
Market median
+87% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2026 | |
| Board of Directors | 2026 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Medomina AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Aida Hot-Bjelak | Deputy Board Member | 0 companies |
| Sabahudin Bjelak | Board of Directors | 0 companies |